NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-OD-22-222 from the NIH Guide for Grants and Contracts
Notice NOT-HL-22-051 from the NIH Guide for Grants and Contracts
Notice NOT-HD-22-049 from the NIH Guide for Grants and Contracts
Notice NOT-HL-22-050 from the NIH Guide for Grants and Contracts
Notice NOT-AT-23-003 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-22-236 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications that seek to advance or clinically validate emerging novel approaches for the development of safe, real-time, non-invasive (or minimally invasive) methods to assess the development and function of the human placenta across pregnancy.
Funding Opportunity PAR-22-237 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications that seek to advance or clinically validate emerging novel approaches for the development of safe, real-time, non-invasive (or minimally invasive) methods to assess the development and function of the human placenta across pregnancy.
Notice NOT-HD-22-048 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HG-22-026 from the NIH Guide for Grants and Contracts. The Diversity Center for Genome Research (DCGR) program aims to establish Genomic Research Centers at Minority Serving Institutions (MSIs) as defined in Part 2, section III of the FOA. The MSIs must have a mission to serve historically underrepresented populations in biomedical research that award doctorate degrees in the health professions or the sciences related to health, and have received an average of less than $50 million per year in NIH support and less than $25 million per year of R01 total cost of NIH support for the past three fiscal years. Each DCGR award will support a multi-investigator, interdisciplinary team to develop 2-3 interrelated, innovative genomic research projects. Each project should address one or more critical issues in genomics including: genomic technology and methods development; genome structure; genome function; genomics of disease; use and impact of genomic information in clinical care; genomic data science and computational genomics; ethical, legal, and social implications of genomic research; and/or genomics and health equity. Along with its scientific goals, the DCGR should expand the pool of diverse genomic scientists, clinician scientists, and researchers who can perform innovative genomics research by providing didactic, practicum and research activities and experiences that are aligned with the research projects.
Funding Opportunity RFA-HG-22-027 from the NIH Guide for Grants and Contracts. Funding Opportunity PurposeThe full-scale Diversity Centers for Genome Research (DCGR) program aims to establish Genomic Research Centers at Minority Serving Institutions (MSIs) as defined in Part 2, section III of the FOA. The MSIs must have a mission to serve historically underrepresented populations in biomedical research that award doctorate degrees in the health professions or the sciences related to health, and have received an average of less than $50 million per year in NIH support and less than $25 million per year of R01 total cost of NIH support for the past three fiscal years. The purpose of this FOA is to call for applications for UG3/UH3 cooperative agreements to support the development and planning for a multi-investigator, interdisciplinary team to develop administrative, genomic workforce development and community engagement cores and 2-3 interrelated, innovative genomic research projects that address one or more critical issues in genomics including: genomic technology and methods development; genome structure; genome function; genomics of disease; use and impact of genomic information in clinical care; genomic data science and computational genomics, ethical, legal, and social implications of genomic research (ELSI); and/or genomics and health equity. The outcome of the development and feasibility studies will be fully developed plans to carry out all activities of a full-scale Diversity Center for Genome Research. Along with its scientific goals, the DCGR should expand the pool of diverse genomic scientists, clinician scientists, and researchers who can perform innovative genomics research by providing didactic, practicum and research activities and experiences that are aligned with the research projects.
Notice NOT-DK-22-030 from the NIH Guide for Grants and Contracts
Notice NOT-MH-22-315 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-22-255 from the NIH Guide for Grants and Contracts. The primary purpose of the AHRQ Mentored Research Scientist Career Development Awards (K01) program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's health services research needs. This AHRQ program provides support and protected time to individuals with a research doctoral degree for an intensive, supervised research career development experience in health services research. The K01 award can be used both by individuals who propose to newly embark in health services research training and those who had a hiatus in their research careers because of illness or family circumstances.
Notice NOT-OD-22-216 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-22-241 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits R01 grant applications that propose independent research projects that are within the scientific mission areas of the participating NIH Institutes or Centers. This program is intended to support New Investigators and At-Risk Investigators from diverse backgrounds, including those from groups underrepresented in the health-related sciences. Investigators from diverse backgrounds, including those from underrepresented groups (e.g., see NOT-OD-20-031, Notice of NIHs Interest in Diversity), are encouraged to work with their institutions to apply for support under this program eligible to apply. Investigators from categories A and B are particularly encouraged to work with their institutions to apply
Notice NOT-OD-22-214 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-213 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-217 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-215 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AI-22-059 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to establish a consortium of tuberculosis (TB) preclinical and clinical experts to systematically refine preclinical models by analyses of relevant pre-clinical and clinical data, and to provide results from optimized models to identify the most promising combination regimens for clinical testing